• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Infliximab Product Approval Info - Licensing Action

Proper name: Infliximab
Tradename: Remicade
Manufacturer: Centocor, Inc, Malvern, PA, License #1242
Indication for Use: Reduction in signs and symptoms of rheumatoid arthritis in patients who have had an inadequate response to methotrexate
Approval Date: 11/10/99
Type of submission: Biologics license application supplement


Approval Letter (PDF)

Label (PDF)

Statistical Review (PDF)

Pharmacology Review (PDF)

Clinical Pharmacology Review (PDF)

Clinical Review (PDF)